Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ARVIND REMEDIES vs SYNCOM FORMULATIONS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ARVIND REMEDIES SYNCOM FORMULATIONS ARVIND REMEDIES/
SYNCOM FORMULATIONS
 
P/E (TTM) x -0.2 55.3 - View Chart
P/BV x - 6.4 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ARVIND REMEDIES   SYNCOM FORMULATIONS
EQUITY SHARE DATA
    ARVIND REMEDIES
Jun-15
SYNCOM FORMULATIONS
Mar-24
ARVIND REMEDIES/
SYNCOM FORMULATIONS
5-Yr Chart
Click to enlarge
High Rs6619 354.2%   
Low Rs106 172.4%   
Sales per share (Unadj.) Rs115.52.8 4,122.3%  
Earnings per share (Unadj.) Rs-47.00.3 -17,440.9%  
Cash flow per share (Unadj.) Rs-42.60.3 -13,345.3%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-6.23.1 -202.4%  
Shares outstanding (eoy) m68.14940.00 7.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.34.4 7.5%   
Avg P/E ratio x-0.845.4 -1.8%  
P/CF ratio (eoy) x-0.938.3 -2.3%  
Price / Book Value ratio x-6.14.0 -153.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,59111,492 22.5%   
No. of employees `000NANA-   
Total wages/salary Rs m160336 47.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7,8712,634 298.8%  
Other income Rs m59135 43.3%   
Total revenues Rs m7,9292,769 286.3%   
Gross profit Rs m-2,306299 -772.0%  
Depreciation Rs m29547 624.0%   
Interest Rs m71147 1,505.4%   
Profit before tax Rs m-3,253340 -958.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-5286 -60.7%   
Profit after tax Rs m-3,200253 -1,264.3%  
Gross profit margin %-29.311.3 -258.4%  
Effective tax rate %1.625.4 6.3%   
Net profit margin %-40.79.6 -423.1%  
BALANCE SHEET DATA
Current assets Rs m5,0012,748 182.0%   
Current liabilities Rs m5,9181,065 555.6%   
Net working cap to sales %-11.763.9 -18.3%  
Current ratio x0.82.6 32.8%  
Inventory Days Days4102 3.8%  
Debtors Days Days2,2141,432 154.7%  
Net fixed assets Rs m2,8371,299 218.4%   
Share capital Rs m681940 72.5%   
"Free" reserves Rs m-1,1041,941 -56.9%   
Net worth Rs m-4232,881 -14.7%   
Long term debt Rs m1,9380-   
Total assets Rs m7,8384,047 193.7%  
Interest coverage x-3.68.2 -43.7%   
Debt to equity ratio x-4.60-  
Sales to assets ratio x1.00.7 154.3%   
Return on assets %-31.87.4 -428.0%  
Return on equity %757.08.8 8,616.9%  
Return on capital %-167.813.4 -1,250.4%  
Exports to sales %0.365.0 0.5%   
Imports to sales %02.7 0.0%   
Exports (fob) Rs m271,711 1.6%   
Imports (cif) Rs mNA72 0.0%   
Fx inflow Rs m271,711 1.6%   
Fx outflow Rs m077 0.0%   
Net fx Rs m271,635 1.6%   
CASH FLOW
From Operations Rs m-1,512-60 2,537.0%  
From Investments Rs m1,050830 126.5%  
From Financial Activity Rs m439-146 -301.5%  
Net Cashflow Rs m-23625 -3.6%  

Share Holding

Indian Promoters % 3.6 50.6 7.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.1 20.0%  
FIIs % 0.0 0.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 96.4 49.4 195.1%  
Shareholders   71,277 469,242 15.2%  
Pledged promoter(s) holding % 55.8 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ARVIND REMEDIES With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on ARVIND REMEDIES vs SYNCOM FORMULATIONS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ARVIND REMEDIES vs SYNCOM FORMULATIONS Share Price Performance

Period ARVIND REMEDIES SYNCOM FORMULATIONS S&P BSE HEALTHCARE
1-Day -4.86% -1.06% 1.23%
1-Month -10.82% 2.41% -0.24%
1-Year -64.58% 76.72% 43.62%
3-Year CAGR -45.48% 27.24% 20.35%
5-Year CAGR -32.03% 95.68% 26.24%

* Compound Annual Growth Rate

Here are more details on the ARVIND REMEDIES share price and the SYNCOM FORMULATIONS share price.

Moving on to shareholding structures...

The promoters of ARVIND REMEDIES hold a 3.6% stake in the company. In case of SYNCOM FORMULATIONS the stake stands at 50.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ARVIND REMEDIES and the shareholding pattern of SYNCOM FORMULATIONS.

Finally, a word on dividends...

In the most recent financial year, ARVIND REMEDIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

SYNCOM FORMULATIONS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ARVIND REMEDIES, and the dividend history of SYNCOM FORMULATIONS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.